Published in J Nat Prod on March 01, 2006
Proteasome-inhibitory and cytotoxic constituents of Garcinia lateriflora: absolute configuration of caged xanthones. Tetrahedron (2010) 0.89
Gastroprotective effects of extracts and guttiferone A isolated from Garcinia achachairu Rusby (Clusiaceae) against experimentally induced gastric lesions in mice. Naunyn Schmiedebergs Arch Pharmacol (2012) 0.84
Computational studies on sirtuins from Trypanosoma cruzi: structures, conformations and interactions with phytochemicals. PLoS Negl Trop Dis (2014) 0.84
Antimicrobial activity, toxicity and selectivity index of two biflavonoids and a flavone isolated from Podocarpus henkelii (Podocarpaceae) leaves. BMC Complement Altern Med (2014) 0.84
Antitrypanosomal activity of some medicinal plants from Nigerian ethnomedicine. Parasitol Res (2011) 0.80
Cellular antioxidative, cytotoxic, and antileishmanial activities of Homalium letestui. Avicenna J Phytomed (2013) 0.79
The traditional antidiarrheal remedy, Garcinia buchananii stem bark extract, inhibits propulsive motility and fast synaptic potentials in the guinea pig distal colon. Neurogastroenterol Motil (2010) 0.78
Phytochemical, Antioxidant and Anticancer Activities of Extracts of Seven Fruits Found in the Southern Brazilian Flora. Indian J Pharm Sci (2016) 0.75
Anti-infective potential of natural products: how to develop a stronger in vitro 'proof-of-concept'. J Ethnopharmacol (2006) 4.72
Role of anthocyanidin reductase, encoded by BANYULS in plant flavonoid biosynthesis. Science (2003) 3.26
High-dose folic acid pretreatment blunts cardiac dysfunction during ischemia coupled to maintenance of high-energy phosphates and reduces postreperfusion injury. Circulation (2008) 2.47
Stereoselective synthesis of monomeric flavonoids. Phytochemistry (2005) 2.23
Circular dichroism, a powerful tool for the assessment of absolute configuration of flavonoids. Phytochemistry (2005) 2.07
Genistein. Phytochemistry (2002) 1.71
In vitro susceptibilities of Leishmania donovani promastigote and amastigote stages to antileishmanial reference drugs: practical relevance of stage-specific differences. Antimicrob Agents Chemother (2009) 1.66
Antifungal activity of some Tanzanian plants used traditionally for the treatment of fungal infections. J Ethnopharmacol (2006) 1.64
Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives. Phytochemistry (2006) 1.53
Advancing drug innovation for neglected diseases-criteria for lead progression. PLoS Negl Trop Dis (2009) 1.48
Reversal of fluconazole resistance by sulfated sterols from the marine sponge Topsentia sp. J Nat Prod (2009) 1.46
Quorum sensing inhibitors increase the susceptibility of bacterial biofilms to antibiotics in vitro and in vivo. Antimicrob Agents Chemother (2011) 1.46
Antioxidant, antimalarial and antimicrobial activities of tannin-rich fractions, ellagitannins and phenolic acids from Punica granatum L. Planta Med (2007) 1.42
Theoretical calculation of electronic circular dichroism of the rotationally restricted 3,8''-biflavonoid morelloflavone. J Org Chem (2007) 1.36
Experience of initiating collaboration of traditional healers in managing HIV and AIDS in Tanzania. J Ethnobiol Ethnomed (2007) 1.32
Phytoestrogens: recent developments. Planta Med (2003) 1.27
Antimicrobial activity and brine shrimp toxicity of extracts of Terminalia brownii roots and stem. BMC Complement Altern Med (2007) 1.27
Molecular and biochemical analysis of two cDNA clones encoding dihydroflavonol-4-reductase from Medicago truncatula. Plant Physiol (2004) 1.26
Leishmania-macrophage interactions: insights into the redox biology. Free Radic Biol Med (2011) 1.23
Oral manifestations of HIV infection in children and adults receiving highly active anti-retroviral therapy [HAART] in Dar es Salaam, Tanzania. BMC Oral Health (2006) 1.22
Species distribution and in vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasis. BMC Microbiol (2008) 1.17
Theoretical calculation of electronic circular dichroism of a hexahydroxydiphenoyl-containing flavanone glycoside. J Nat Prod (2009) 1.13
Linking in vitro and in vivo survival of clinical Leishmania donovani strains. PLoS One (2010) 1.12
In vitro antioxidant profile of phenolic acid derivatives. Free Radic Res (2002) 1.10
Pomegranate phenolics from the peels, arils, and flowers are antiatherogenic: studies in vivo in atherosclerotic apolipoprotein e-deficient (E 0) mice and in vitro in cultured macrophages and lipoproteins. J Agric Food Chem (2008) 1.07
Synthesis, antifungal activity, and structure-activity relationships of coruscanone A analogues. J Med Chem (2006) 1.07
Antitrypanosomal activity of triterpenoids and sterols from the leaves of Strychnos spinosa and related compounds. J Nat Prod (2007) 1.07
Screening of traditionally used plants for in vivo antimalarial activity in mice. Afr J Tradit Complement Altern Med (2009) 1.06
Integrated dataset of screening hits against multiple neglected disease pathogens. PLoS Negl Trop Dis (2011) 1.03
Antimalarial versus cytotoxic properties of dual drugs derived from 4-aminoquinolines and Mannich bases: interaction with DNA. J Med Chem (2010) 1.03
The antiplasmodial activity of isolates from Ajuga remota. J Nat Prod (2002) 1.03
Antimonial resistance in Leishmania donovani is associated with increased in vivo parasite burden. PLoS One (2011) 1.03
Drug to genome to drug: discovery of new antiplasmodial compounds. J Med Chem (2011) 1.02
Hypoxia-inducible factor-1 activation by (-)-epicatechin gallate: potential adverse effects of cancer chemoprevention with high-dose green tea extracts. J Nat Prod (2004) 1.01
Assessment of the short-term safety and tolerability of a quantified 80 % ethanol extract from the stem bark of Nauclea pobeguinii (PR 259 CT1) in healthy volunteers: a clinical phase I study. Planta Med (2010) 1.01
Capisterones A and B, which enhance fluconazole activity in Saccharomyces cerevisiae, from the marine green alga Penicillus capitatus. J Nat Prod (2006) 1.01
In vitro sensitivity testing of Leishmania clinical field isolates: preconditioning of promastigotes enhances infectivity for macrophage host cells. Antimicrob Agents Chemother (2009) 1.01
Validation of a simple resazurin-based promastigote assay for the routine monitoring of miltefosine susceptibility in clinical isolates of Leishmania donovani. Parasitol Res (2012) 1.00
Schisandrene, a dibenzocyclooctadiene lignan from Schisandra chinensis: structure-antioxidant activity relationships of dibenzocyclooctadiene lignans. J Nat Prod (2006) 1.00
Catechol pyrazolinones as trypanocidals: fragment-based design, synthesis, and pharmacological evaluation of nanomolar inhibitors of trypanosomal phosphodiesterase B1. J Med Chem (2012) 0.99
Interactions of cryptolepine and neocryptolepine with unusual DNA structures. Biochimie (2003) 0.99
Experimental induction of paromomycin resistance in antimony-resistant strains of L. donovani: outcome dependent on in vitro selection protocol. PLoS Negl Trop Dis (2012) 0.98
Synthesis, cytotoxicity, and antiplasmodial and antitrypanosomal activity of new neocryptolepine derivatives. J Med Chem (2002) 0.98
Polyphenols isolated from antiradical extracts of Mallotus metcalfianus. Phytochemistry (2008) 0.98
Antitrypanosomal activity of 1,2-dihydroquinolin-6-ols and their ester derivatives. J Med Chem (2010) 0.96
In vitro and in vivo activities of a triterpenoid saponin extract (PX-6518) from the plant Maesa balansae against visceral leishmania species. Antimicrob Agents Chemother (2004) 0.95
Anti-infective discorhabdins from a deep-water alaskan sponge of the genus Latrunculia. J Nat Prod (2010) 0.95
The influence of pomegranate by-product and punicalagins on selected groups of human intestinal microbiota. Int J Food Microbiol (2010) 0.95
In vitro antiplasmodial, antileishmanial and antitrypanosomal activities of selected medicinal plants used in the traditional Arabian Peninsular region. BMC Complement Altern Med (2012) 0.95
Microbial metabolism. Part 6. Metabolites of 3- and 7-hydroxyflavones. Chem Pharm Bull (Tokyo) (2006) 0.95
Trypanosoma brucei glycogen synthase kinase-3, a target for anti-trypanosomal drug development: a public-private partnership to identify novel leads. PLoS Negl Trop Dis (2011) 0.95
Newbouldiosides A-C, phenylethanoid glycosides from the stem bark of Newbouldia laevis. Phytochemistry (2006) 0.95
In vivo antioxidative activity of a quantified Pueraria lobata root extract. J Ethnopharmacol (2009) 0.94
Antiparasitic alkaloids from Psychotria klugii. J Nat Prod (2003) 0.94
9,19-cyclolanostane derivatives from the roots of Actaea pachypoda. J Nat Prod (2007) 0.94
Screening of some Tanzanian medicinal plants from Bunda district for antibacterial, antifungal and antiviral activities. J Ethnopharmacol (2008) 0.94
Sorocenols G and H, anti-MRSA oxygen heterocyclic Diels-Alder-type adducts from Sorocea muriculata roots. J Nat Prod (2008) 0.94
Enantiomeric discorhabdin alkaloids and establishment of their absolute configurations using theoretical calculations of electronic circular dichroism spectra. J Org Chem (2008) 0.94
Cytotoxic diterpenoids from the hybrid soft coral Sinularia maxima x Sinularia polydactyla. J Nat Prod (2007) 0.93
Colon cancer chemopreventive activities of pomegranate ellagitannins and urolithins. J Agric Food Chem (2010) 0.93
Plant-derived leading compounds for chemotherapy of human immunodeficiency virus (HIV) infection - an update (1998 - 2007). Planta Med (2008) 0.93
Efficacy and tolerability of oleylphosphocholine (OlPC) in a laboratory model of visceral leishmaniasis. J Antimicrob Chemother (2012) 0.92
Antiplasmodial activity of (I-3,II-3)-biflavonoids and other constituents from Ormocarpum kirkii. Phytochemistry (2010) 0.92
In vitro activities of plant extracts from Saudi Arabia against malaria, leishmaniasis, sleeping sickness and Chagas disease. Phytother Res (2010) 0.92
Structure-activity relationship of cinnamaldehyde analogs as inhibitors of AI-2 based quorum sensing and their effect on virulence of Vibrio spp. PLoS One (2011) 0.91
Flavonolignans from Avena sativa. J Nat Prod (2005) 0.91
Legal requirements for the quality of herbal substances and herbal preparations for the manufacturing of herbal medicinal products in the European union. Planta Med (2009) 0.91